V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20216479 | 20155904 | 1.63 | 0 | Palliative (P) | 2018-09-29 | 2018-10-15 | EOX | N | N | CETUXIMAB + IRINOTECAN + MDG | 101388287 |
| 20216482 | 20155905 | 1.66 | 60 | Disease modification (D) | 2018-04-30 | 2018-05-20 | EOX | 01 | Y | CETUXIMAB + IRINOTECAN + MDG | 100608251 |
| 20216484 | 20155906 | 1.72 | null | null | 2020-05-11 | 2020-05-18 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100837674 |
| 20216490 | 20155907 | 1.69 | 75.4 | Palliative (P) | 2017-08-09 | 2017-08-23 | Sorafenib | 02 | null | SORAFENIB | 100136498 |
| 20216493 | 20155908 | 1.6 | 61.5 | Palliative (P) | 2017-11-14 | 2018-03-18 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100876878 |
| 20216501 | 20155909 | 1.71 | 52.1 | Palliative (P) | 2017-12-25 | 2018-01-02 | EOX | 02 | N | TRIAL | 101293522 |
| 20216513 | 20155910 | 1.7 | 84.25 | null | null | 2017-02-09 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100200803 |
| 20216517 | 20155911 | null | null | Curative (C) | 2014-05-30 | 2016-05-16 | EOX | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100323363 |
| 20216518 | 20155912 | 1.61 | 50 | null | 2021-07-14 | 2022-05-27 | EOX | 02 | Y | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100728111 |
| 20216519 | 20155913 | 1.93 | 79.4 | Disease modification (D) | 2016-09-05 | 2016-09-05 | Cetuximab + FOLFIRI cycle1 | 02 | Y | CETUXIMAB + IRINOTECAN + MDG | 101335262 |
| 20216522 | 20155914 | 1.86 | 90.8 | null | 2018-01-28 | 2018-02-08 | EOX | 02 | Y | OXALIPLATIN + RALTITREXED | 100486502 |
| 20216523 | 20155915 | null | 0 | Palliative (P) | 2016-10-08 | 2017-12-04 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 100161836 |
| 20216525 | 20155916 | 1.83 | 54.7 | null | 2018-08-17 | 2018-09-03 | CAPECITABINE + RT | 02 | null | CAPECITABINE + RT | 100314285 |
| 20216527 | 20155917 | null | null | Palliative (P) | 2019-01-12 | 2019-03-10 | EOX | 2 | N | EOX | 101609790 |
| 20216528 | 20155918 | 0 | 52.2 | Palliative (P) | null | 2020-09-10 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100472166 |
| 20216538 | 20155919 | 1.74 | 83 | null | 2016-11-08 | 2017-01-02 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 100368325 |
| 20216539 | 20155920 | 1.72 | 68.6 | Curative (C) | 2019-05-24 | 2019-06-03 | IRINOTECAN + MDG + PANITUMUMAB | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100949925 |
| 20216541 | 20155921 | 1.83 | 84 | null | 2018-11-29 | 2019-06-03 | EOX | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 100750855 |
| 20216542 | 20155922 | null | null | null | 2017-07-17 | 2017-09-12 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 100867680 |
| 20216545 | 20155923 | 1.7 | 60 | Palliative (P) | 2017-02-06 | 2017-02-06 | Sorafenib | 02 | N | SORAFENIB | 100875012 |
| 20216547 | 20155924 | 0 | 93 | Curative (C) | 2019-01-07 | 2019-01-10 | EOX | 02 | N | TRIAL | 100543523 |
| 20216554 | 20155925 | 1.66 | 62.6 | null | 2018-06-09 | 2019-12-12 | Oxaliplatin + Raltitrexed | 02 | null | OXALIPLATIN + RALTITREXED | 101473135 |
| 20216557 | 20155926 | null | null | Palliative (P) | 2019-10-09 | 2020-05-14 | Capecitabine 35days + RT | N | N | CAPECITABINE + RT | 100582991 |
| 20216562 | 20155927 | 1.72 | 82.65 | Neo-adjuvant (N) | 2020-01-30 | 2020-05-23 | IRINOTECAN + MDG + PANITUMUMAB | 02 | 2 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100008372 |
| 20216566 | 20155928 | 1.7 | 86.9 | Disease modification (D) | 2021-12-11 | 2022-01-10 | EOX | 02 | Y | OXALIPLATIN + RALTITREXED | 101644618 |
| 20216568 | 20155929 | 1.6 | 75.3 | Palliative (P) | 2016-10-08 | 2017-09-15 | EOX | N | N | EOX | 100167681 |
| 20216573 | 20155930 | 1.64 | 55.7 | Palliative (P) | 2019-02-12 | 2019-02-12 | EOX | 02 | N | CAPECITABINE + RT | 100478797 |
| 20216576 | 20155931 | 1.72 | 71.4 | null | 2019-10-13 | 2020-09-18 | Sorafenib | 02 | null | SORAFENIB | 101100118 |
| 20216578 | 20155932 | 0 | 98.3 | Palliative (P) | 2019-08-02 | 2019-08-16 | GO2 TRIAL | N | N | TRIAL | 101509275 |
| 20216580 | 20155933 | 1.69 | 62.8 | Palliative (P) | 2020-05-17 | 2020-07-04 | EOX | N | N | EOX | 101624573 |
| 20216581 | 20155934 | 1.76 | 73.8 | null | 2017-03-05 | 2017-03-11 | CETUXIMAB + IRINOTECAN + MDG | 2 | null | CETUXIMAB + IRINOTECAN + MDG | 100401974 |
| 20216582 | 20155935 | 1.83 | 80 | Palliative (P) | 2019-04-06 | 2019-05-02 | Cetuximab + Oxaliplatin + MdG Maint | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101561368 |
| 20216584 | 20155936 | null | 118.5 | Neo-adjuvant (N) | 2019-02-01 | 2019-07-18 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101593358 |
| 20216588 | 20155937 | 1.73 | 85.4 | null | 2021-03-16 | 2021-04-13 | EOX | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101753902 |
| 20216589 | 20155938 | 1.72 | 65.7 | Palliative (P) | 2018-02-16 | 2018-02-16 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 101552512 |
| 20216594 | 20155939 | 1.75 | 105 | Palliative (P) | 2019-02-03 | 2019-02-19 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100437893 |
| 20216596 | 20155940 | null | 18.9 | Palliative (P) | 2018-08-09 | 2018-09-27 | IRINOTECAN + MDG + PANITUMUMAB | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100202416 |
| 20216598 | 20155941 | 1.66 | 100 | null | 2016-12-01 | 2016-12-06 | EOX | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100329184 |
| 20216600 | 20155942 | 1.59 | 51.35 | Palliative (P) | 2021-01-30 | 2021-02-01 | EOX | 02 | N | SORAFENIB | 100437111 |
| 20216607 | 20155943 | 1.88 | 97.35 | Curative (C) | 2020-03-25 | 2020-03-25 | Capecitabine 35days + RT | 02 | N | CAPECITABINE + RT | 100611291 |
| 20216608 | 20155944 | 1.75 | 68 | Palliative (P) | 2019-12-01 | 2019-12-10 | Sorafenib | 02 | N | SORAFENIB | 100155354 |
| 20216613 | 20155945 | 1.82 | 120 | Palliative (P) | 2016-08-04 | 2016-08-12 | Trial Unspecified | 02 | N | TRIAL | 101035224 |
| 20216617 | 20155946 | 1.81 | 61.3 | Palliative (P) | 2019-06-25 | 2019-07-24 | EOX | 2 | N | EOX | 100315977 |
| 20216618 | 20155947 | 1.64 | 47 | Palliative (P) | null | 2019-09-15 | EOX | 2 | Y | TRIAL | 100292925 |
| 20216621 | 20155948 | 1.49 | 46.2 | Neo-adjuvant (N) | 2018-10-14 | 2019-08-07 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | Y | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101826216 |
| 20216622 | 20155949 | 1.65 | 108 | Curative (C) | 2020-05-02 | 2020-09-06 | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100486874 |
| 20216624 | 20155950 | 1.53 | 107.55 | Palliative (P) | 2018-08-01 | 2019-11-27 | CETUXIMAB + OXALIPLATIN + MDG | 99 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101680703 |
| 20216640 | 20155951 | 1.63 | 56.3 | null | 2017-07-16 | 2017-07-23 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + IRINOTECAN + MDG | 101216275 |
| 20216641 | 20155952 | 1.74 | 58.1 | null | 2017-12-28 | 2017-12-30 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 101537855 |
| 20216643 | 20155953 | 1.71 | 78.5 | Palliative (P) | 2016-12-03 | 2016-12-04 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100392477 |